Buy & Sell Under Armour Inc Class A (UA) – Under Armour Inc Class A Price Today
Aura AI Summary
Key Stats
- $2.15BMarket Cap
- Consumer CyclicalSector
- -37.82%3M Drawdown
- $3.78BEnterprise Value
- -Dividend Yield
- 1 daysTypical Hold Time
Under Armour Inc Class A (UA) is currently valued at a market capitalization of $2.15B, with an enterprise value of $3.78B. Over the past 52 weeks, Under Armour Inc Class A has traded between a low of $3.96 and a high of $7.88, highlighting its annual price range. Over the past three months, Under Armour Inc Class A has recorded a drawdown of -37.82%, reflecting recent price volatility. On average, investors hold Under Armour Inc Class A for approximately 1 days, indicating typical investor behavior on the platform.
About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Most Recent News
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...